InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
+13.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Driscoll Michael Joseph, Director. Officer active across 1 company, notably Organogenesis Holdings Inc.. Cumulatively, 8 filings have been recorded. Breakdown: 2 buys · 1 sell. Total volume traded: €168k. History available since 15 February 2022. The latest transaction was disclosed on 9 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
10,000 shares@ US$2.6688Class A Common StockSEC:0002064832-26-000127:0
Ideal exit: 4 Dec 2026 (T+270)
48,828 shares0Class A Common StockSEC:0002064832-26-000056:0
25,000 shares@ US$5.101483.9% of flowClass A Common StockSEC:0001062993-25-004849:0
49,575 shares0Class A Common StockSEC:0001062993-25-003204:0
51,020 shares0Class A Common StockSEC:0001062993-24-004307:0
65,737 shares0Class A Common StockSEC:0001062993-23-004883:0
5,000 shares@ US$4.8016.1% of flowClass A Common StockSEC:0001062993-22-018041:0
Ideal exit: 9 May 2023 (T+270)
20,547 shares0Class A Common StockSEC:0001062993-22-004819:0
8 of 8 declarations
About Driscoll Michael Joseph
Michael Joseph Driscoll is a Board Member at Organogenesis Holdings Inc. He plays a key role in the governance of the company and contributes to strategic decision-making. His expertise in healthcare is an asset for Organogenesis, which specializes in tissue regeneration solutions.
